FDA approved fezolinetant (Veozah–Astellas Pharma US), a first-in-class neurokinin 3 (NK3) receptor antagonist, for the treatment of moderate to severe vasomotor symptoms (VMS) of menopause in May 2023.

Sonya Collins

The number of annual calls to poison control for pediatric melatonin overdoses increased by a whopping 530% from 2012 to 2021.

Sonya Collins

Updates from FDA

Stinging and biting insects seem to be everywhere during the summer months, and usually cause only a local reaction. But for patients who are sensitive to compounds in the insect’s saliva or venom, bites and stings can cause reactions ranging from swelling to life-threatening anaphylaxis.

Mary Warner

Weight loss is big business with multiple supplements on the market advertising promising results. Glucomannan is one weight loss supplement gaining popularity in patients seeking to reduce cravings and control appetite as a way to lose weight. What’s behind the hype?

Mickie Cathers